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1. Introduction 
The importance of GABA as an inhibitory neuro- 
transmitter in the mammalian cerebellum is well doc- 
umented [ 1,2]. The excitatory granule cells, by far the 
most numerous neuronal type in the cerebellum [3], 
receive input from GABAergic cells [ 11: thus it has 
been suggested that the majority of GABA receptors 
are located on granule neurons [4]. The cerebellar 
mutants, weaver (WV) reeler (rl) and staggerer (sg), 
present an opportunity to test this hypothesis. Anum- 
ber ofworkers have examined GABA receptor binding 
in these mutants [5-71 as well in animals whose cere- 
bella have been depleted of granule cells by viral agents 
[4]. Although the cerebella of sg, WV and rl are to 
various extents depleted of granule cells, the primary 
events which lead to this deficit and the altered cere- 
bellar cytoarchitecture are different for each mutation 
[8,9]. The sg mutant is also deficient in Purkinje neu- 
rons [IO]. The hypomyelinating mutant, jimpy (jp), 
also used in this study, lacks CNS myelin, but cerebel- 
lar organization is normal [ 11 ,121. 
Here we have used the radioligand [3H]muscimol, 
which binds with high affinity to GABA receptors 
[13,14], to compare the development of these recep- 
tors in normal and mutant cerebella. In addition, we 
have examined [3H]muscimol binding to isolated cere- 
bellar glomeruli, which contain the post-synaptic spe- 
cialization of the granule neurons [ 151. The results are 
consistent with the hypothesis that GABA receptors 
are associated with granule neurons. 
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2. Materials and methods 
Animals were raised from stock originally obtained 
from the Jackson Laboratory (Bar Harbor, ME); all 
were of the B6/CBA strain, except for sg mutants, 
which were on a C57BL/6 background. Mutants were 
bred and identified as outlined in [ 161. Controls for 
all the mutants, except sg, were taken from mutant- 
free B6/CBA stock. Sg controls were normal non- 
mutant carriers from the sg colony, and identified by 
their grey coat (marker gene dilute). 
2.1. fieparation of cerebellar glomendi 
Cerebellar glomeruli were produced from adult CBA 
mice (obtained from Olac, Bicester) by a modification 
of the method in [ 151. Briefly, this consisted of chop- 
ping and homogenizing tissue in ice cold 0.3 M sucrose 
(this and all subsequently mentioned solutions con- 
tained 1 mM MgSO& The homogenate was filtered 
through nylon and metal filters and centrifuged. The 
pellet was resuspended in the sucrose solution and 
centrifuged and the above procedure repeated. The 
final pellet was resuspended in 6 ml 0.3 M sucrose and 
2 ml aliquots were layered onto a linear gradient gen- 
erated from 7.5 ml 1.2 M sucrose and 7.5 ml 1.3 M 
sucrose underlayered with a cushion of 1.4 M sucrose. 
Tubes were centrifuged (53 000 X g) 60 min at 3”C, 
and the glomeruli collected from the gradient-cushion 
interface. The glomerular suspension was diluted with 
distilled water and centrifuged (50 000 X g) 30 min 
at 3°C. The pelleted glomeruli were suspended in 2 ml 
distilled water and stored at -20°C. This homogenate 
was treated for analysis as outlined below for the cere- 
bellar homogenates. 
2.2. GABA receptor assay 
[3H] Muscimol binding was determined using a 
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modification of the method in [ 141. Cerebellar tissue 
(25-55 mg wet wt) was homogenized in 2 ml icecold 
distilled water. Homogenates were centrifuged 
(50 000 X g) 20 min at 3’C. Pellets were resuspended 
in 2 ml distilled water and stored at -20°C for 224 h 
before analysis. Just prior to analysis, the homoge- 
nates were made up to 7 ml with ice cold distilled 
water and centrifuged as before. Pellets were resus- 
pended in a further 7 ml ice cold water and centri- 
fuged, and the final pellet resuspended in 2.2 ml ice 
cold water. Duplicate 500 ~1 aliquots of this suspen- 
sion were incubated at 0°C for 10 min with 1 ml 60 
mM Hepes-Tris buffer (pH 6.8) containing N-methyl- 
amine-[3H]muscimol ([3H]muscimol, 19 Ci/mmol, 
Radiochemical Centre, Amersham) in the presence of 
100 /.LM GABA (Sigma). Incubations were terminated 
by centrifugation (50 000 X g, 10 min, 3°C). The 
supernatants were aspirated,and the pellets were solu- 
bilized with 0.1 M NaOH counted by liquid scintilla- 
tion spectroscopy. The apparent dissociation constant 
(Kd) for [3H]muscimol binding was determined using 
a range of [3H]muscimol concentrations from 0.5-33 
nM, otherwise the concentration was fixed at 2.8 nM. 
Specific binding was that displaced by 100 I.IM GABA. 
Binding was linear with protein concentration up to 
0.55 mg protein/incubation, and was maximally dis- 
placed by 100 I.IM GABA. 
3. Results 
[3H]Muscimol was bound with high affinity to a 
single population of receptors with K, = 13 + 1 nM 
and B,,, = 1270 f 100 pmol/g protein (fig.1, [ 171). 
The Kd values at 10 and 20 days of age were not sig- 
nificantly different (fig.1). 
Although significant levels of binding were found 
at all ages examined (0.028 pmol/cerebellum at 5 
days), development of [3H]muscimol binding sites 
occurred mainly postnatally (fig.2). The maximum 
increase in binding occured at 15-20 days and in- 
creased up to 30 days of age. 
With the exception ofjp, [3H]muscimol binding 
Fig.2. The development of [3H]muscimol binding in normal 
mouse cerebellum. Results plotted as mean * SEM, n = 5. 
(-)Dataexpressedaspmol/cerebe~um;(--)dataaspmol/g 
protein. 
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Fig.1. Scatchard plot of [3H]muscimol binding to the total 
particulate fraction of 10 day (0) and 20 day (A) mouse cere- 
bellum. Each point is the mean of 2 expt (range <IS%). The 
binding parameters, calculated from this data by linear regres- 
sion (Edwards, 1967) [ 301 were as follows: 10 days, Kd = 
16.4 + 3.4 nM,B,,, = 310 +_ 48 pmol/g protein; 20 days, 
Kd = 13.0 + 1.4 nM.B,,, = 1282 ?: 105 pmol/g protein. The 
regression coefficients for the linear regressions were 0.86 and 
0.95 for 10 and 20 days, respectively. The difference be- 
tween the Kd values was not statistically significant (t = 0.5 I, 
p < 0.50, 2-tailed Student’s f-test). 
0.3 -I / I 
FOSTNATAL AGE (days) 
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Fip.3. [ 3HjMuscin~ol binding expressed as mean percentage of control + SEM (n = 5) at age 10 and 20 days, respectively: binding/ 
cerebellum (a); bind~g/unit protein (@I. Thebsolutc control values at age 10 days were as follows: WV, rl and jp controls,O.O80 f 
0.012 pmoI/~‘erebeilum, 99 * 10 pmol/g protein; sg controls, 0.070 f 0.1 I pmol/cerebeBum, 67 f 7 pmol/g protein. At 20 days 
the corresponding values were: WV, rl and jp controls, 0.533 f 0.025 pmol/cerebeltum, 273 f 14 pmol/g protein; sg controls, 
0.344 + 0.021 pmol/cerebeJJum, 152 + 11 pmol/g protein. 
Table 1 
Summary of anJysis of variance performed on 
[‘H]muscimol binding (per cerebellum) in mutants and 
their controls 
Mutant Age 
(10 vs 20 days) 
Mutant vs 
control 
WV 28.2 33.7 
sg 17.7 48.5 
rl 32.5 24.4 
jp 381 0.03a 
a p > 0.25 (not significant) 
The experiments were designed for 2 X 2 factorial analysis of 
variance. However, a significant difference in ceU variances 
was observed in all comparisons (p < 0.05,from variance ratio 
distribution statistic). [Homogcneity.of variance is a prerequi- 
site for analysis of variance (Edwards, 1967) 13011. Thus the 
simple effects of age and mutation were computed using a 
modificationof analysis of variance, which takes into account 
the heterogeneity of variance,outlined in Winer (1971) [31]. 
The F ratios are given above for the simple effects of age and 
mutation (n = 5, 1 and 19 degrees of freedom). All F ratios 
are highly significant @ < 0.001) unless indicated otherwise 
was reduced in all mutant cerebella (fig.3, also see 
table 1 for a summary of analysis of variance of these 
data}. B~d~n~~erebe~um was most reduced in sg to 
I 1% and 4% of control values at 10 and 20 days, re- 
spectively. The corresponding values for WV were 41% 
and 12% and for rl, 34% and 19%. Although binding 
in all cerebellar mutants decreased over this period 
relative to controls, absolute values increased as did 
the controls. The concentration of [3H]nluscimol 
binding sites in preparations enriched in cerebellar 
glomeruli was -3-fold greater than that of the total 
particulate fraction (table 2). 
Table 2 
The binding of [3H]muscimoi and 13H]QNB (pmol/g 
protein) to fractions enriched in cerebetiar glomeruii 
Ligand Total homogenate Glomerular fraction 
~3Hl~u~imol 431 * 159 1076 + 29Sa 
[%IQNB 1522 30 1425 10 
a Significantly different from total homogenate value t = 
3.363, P < 0.05 (2-tailed Student’s i-test) 
Valuesexpressed as mean i SEM (n = 3) 
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4. Discussion 
Since the cerebellum is undergoing rapid develop- 
ment over the period studied [21] and because the 
cerebellar weights of mutant animals are much reduced 
with respect o their controls, data concerning changes 
in the concentration of binding sites can be misleading 
[ 181. For this reason the results are discussed in terms 
of binding cerebellum unless stated otherwise. 
The age of maximal cerebellar binding (1.3 pmol/ 
mg protein, fig.1 ) was similar to that observed by 
other workers for rat and mouse cerebral cortex [ 12, 
14,191. The k’, for muscimol binding in mouse cere- 
bellar tissue (13 nM at 20 days, fig.1) was similar to 
that reported for high affinity binding to mouse cere- 
bral cortex [ 191, but higher than those in [ 13,141. 
The biphasic nature of binding reported in [ 13,191 
was not observed in this study. At the concentration 
of muscimol used here, binding was limited to a single 
population of high affinity sites. The Kd-values for 
binding to cerebellar tissue in 10 and 20 day animals 
did not change. Thus the increases seen during devel- 
opment were due to an increase in the number of 
sites and not a change in receptor affinity. The iC, 
of muscimol binding in mutant cerebella could not 
be determined due to the unavailability of the large 
amounts of tissue necessary. It was thus assumed that 
any differences observed in muscimol binding to mu- 
tant cerebellar tissue were due to changes in the num- 
ber of receptors. 
The developmental profile for muscimol binding 
(fig.2) followed that reported for sodium-independent 
GABA binding to rat cerebellar material [20]. The 
major increase in muscimol binding occurred relatively 
late during development (15-20 days, fig.2) coin- 
ciding with the later stages of granule cell migration 
[21]. These data are consistent with the majority of 
GABA receptors being localized on granule neurons. 
This conclusion was further supported by the finding 
that muscimol binding levels were elevated in cerebel- 
lar glomeruli, which contain golgi axon terminals and 
granule cell dendrites. Receptor formation may pre- 
teed synaptogenesis [22,23]. The significant levels of 
muscimol binding observed in 5 day mouse cerebellum 
suggests that this may be true for GABA receptors in 
the cerebellum, since according to [21], earliest 
GABAergic synapses appear around day 7. 
Although the most marked feature of the cerebellar 
mutants is the granule cell deficit, other anomalies 
occur [24-291. However, the finding that muscimol 
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binding is severely reduced in the cerebella of these 
animals (fig.3) strongly suggests that a large proportion 
of the muscimol binding defecit is due to the loss of 
granule cells. The binding deficit, while similar for WV 
and rl, is more marked for sg (fig.3). Whether the in- 
creased deficit in sg is the result of known Purkinje 
cell loss is unclear. However, the reduced levels of the 
GABA synthetic enzyme, glutamate decarboxylase in 
sg compared with WV [ 181, suggest less GABAergic 
neuron activity in sg. 
In all cerebellar mutants the deficit in muscimol 
binding relative to controls became larger over I O-20 
days (fig.3) indicating that perhaps the responsible 
processes continue to operate over this period. These 
may include death and/or shortfall in maturing granule 
cells which occur maximally at lo-21 days [ZS]. The 
relatively normal levels of muscimol binding seen in 
jp mutant is consistent with the apparent normal neu- 
ronal development of the cerebellum of these animals 
[ll-131. 
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